Can Non-lytic CD8+ T Cells Drive HIV-1 Escape?

English version České info

The CD8+ T cell effector mechanisms that mediate control of HIV-1 and SIV infections remain poorly understood. Recent work suggests that the mechanism may be primarily non-lytic. This is in apparent conflict with the observation that SIV and HIV-1 variants that escape CD8+ T cell surveillance are frequently selected. Whilst it is clear that a variant that has escaped a lytic response can have a fitness advantage compared to the wild-type, it is less obvious that this holds in the face of non-lytic control where both wild-type and variant infected cells would be affected by soluble factors. In particular, the high motility of T cells in lymphoid tissue would be expected to rapidly destroy local effects making selection of escape variants by non-lytic responses unlikely. The observation of frequent HIV-1 and SIV escape poses a number of questions. Most importantly, is the consistent observation of viral escape proof that HIV-1- and SIV-specific CD8+ T cells lyse infected cells or can this also be the result of non-lytic control? Additionally, the rate at which a variant strain escapes a lytic CD8+ T cell response is related to the strength of the response. Is the same relationship true for a non-lytic response? Finally, the potential anti-viral control mediated by non-lytic mechanisms compared to lytic mechanisms is unknown. These questions cannot be addressed with current experimental techniques nor with the standard mathematical models. Instead we have developed a 3D cellular automaton model of HIV-1 which captures spatial and temporal dynamics. The model reproduces in vivo HIV-1 dynamics at the cellular and population level. Using this model we demonstrate that non-lytic effector mechanisms can select for escape variants but that outgrowth of the variant is slower and less frequent than from a lytic response so that non-lytic responses can potentially offer more durable control.

Vyšlo v časopise: Can Non-lytic CD8+ T Cells Drive HIV-1 Escape?. PLoS Pathog 9(11): e32767. doi:10.1371/journal.ppat.1003656
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003656

Souhrn

Zdroje

1. SchmitzJE, KurodaMJ, SantraS, SassevilleVG, SimonMA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science (New York, NY) 283: 857–860.

2. WiviottLD, WalkerCM, LevyJA (1990) CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell Immunol 128: 628–634.

3. YangOO, KalamsSA, TrochaA, CaoH, LusterA, et al. (1997) Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. Journal of Virology 71: 3120–3128.

4. Geiben-LynnR (2002) Anti-human immunodeficiency virus noncytolytic CD8+ T-cell response: a review. AIDS Patient Care and STDs 16: 471–477.

5. DeVicoAL, GalloRC (2004) Control of HIV-1 infection by soluble factors of the immune response. Nature Reviews Microbiology 2: 401–413.

6. WalkerCM, EricksonAL, HsuehFC, LevyJA (1991) Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells by CD8+ cells involves a noncytotoxic mechanism. J Virol 65: 5921–5927.

7. WalkerCM, LevyJA (1989) A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66: 628–630.

8. LevyJA, MackewiczCE, BarkerE (1996) Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. Immunol Today 17: 217–224.

9. WalkerCM, MoodyDJ, StitesDP, LevyJA (1986) CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563–1566.

10. HammerSM, GillisJM, GroopmanJE, RoseRM (1986) In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. Proc Natl Acad Sci U S A 83: 8734–8738.

11. NakashimaH, YoshidaT, HaradaS, YamamotoN (1986) Recombinant human interferon gamma suppresses HTLV-III replication in vitro. Int J Cancer 38: 433–436.

12. WongGH, KrowkaJF, StitesDP, GoeddelDV (1988) In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol 140: 120–124.

13. AgyMB, AckerRL, SherbertCH, KatzeMG (1995) Interferon Treatment Inhibits Virus Replication in HIV-1- and SIV-Infected CD4+ T-Cell Lines by Distinct Mechanisms: Evidence for Decreased Stability and Aberrant Processing of HIV-1 Proteins. Virology 214: 379–386.

14. KoyanagiY, O'BrienWA, ZhaoJQ, GoldeDW, GassonJC, et al. (1988) Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241: 1673–1675.

15. YamadaO, HattoriN, KurimuraT, KitaM, KishidaT (1988) Inhibition of growth of HIV by human natural interferon in vitro. AIDS Res Hum Retroviruses 4: 287–294.

16. YamamotoJK, Barre-SinoussiF, BoltonV, PedersenNC, GardnerMB (1986) Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2. J Interferon Res 6: 143–152.

17. BrinchmannJE, GaudernackG, VartdalF (1991) In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFN alpha 2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN beta, rIFN gamma, or recombinant tumor necrosis factor-alpha. J Acquir Immune Defic Syndr 4: 480–488.

18. CocchiF, DeVicoAL, Garzino-DemoA, AryaSK, GalloRC, et al. (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (New York, NY) 270: 1811–1815.

19. Garzino-DemoA, DeVicoAL, ConantKE, GalloRC (2000) The role of chemokines in human immunodeficiency virus infection. Immunol Rev 177: 79–87.

20. LiuH, ChaoD, NakayamaEE, TaguchiH, GotoM, et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96: 4581–4585.

21. MackewiczCE, BarkerE, GrecoG, Reyes-TeranG, LevyJA (1997) Do beta-chemokines have clinical relevance in HIV infection? J Clin Invest 100: 921–930.

22. SahaK, BentsmanG, ChessL, VolskyDJ (1998) Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J Virol 72: 876–881.

23. ChenCH, WeinholdKJ, BartlettJA, BolognesiDP, GreenbergML (1993) CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses 9: 1079–1086.

24. CopelandKF, McKayPJ, RosenthalKL (1995) Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res Hum Retroviruses 11: 1321–1326.

25. MackewiczCE, BlackbournDJ, LevyJA (1995) CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci U S A 92: 2308–2312.

26. KlattNR, ShudoE, OrtizAM, EngramJC, PaiardiniM, et al. (2010) CD8+ Lymphocytes Control Viral Replication in SIVmac239-Infected Rhesus Macaques without Decreasing the Lifespan of Productively Infected Cells. PLoS Pathog 6: e1000747–e1000747.

27. WongJK, StrainMC, PorrataR, ReayE, Sankaran-WaltersS, et al. (2010) In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells. PLoS Pathog 6: e1000748–e1000748.

28. ElemansM, Seich Al BasatenaN-K, KlattNR, GkekasC, SilvestriG, et al. (2011) Why Don't CD8+ T Cells Reduce the Lifespan of SIV-Infected Cells In Vivo? PLoS Computational Biology 7: e1002200–e1002200.

29. WickWD, YangOO (2012) Biologically-Directed Modeling Reflects Cytolytic Clearance of SIV-Infected Cells In Vivo in Macaques. PLoS ONE 7(9): e44778 doi:10.1371/journal.pone.0044778

30. KlenermanP, PhillipsRE, RinaldoCR, WahlLM, OggG, et al. (1996) Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proceedings of the National Academy of Sciences of the United States of America 93: 15323–15328.

31. AlmeidaJR, PriceDA, PapagnoL, ArkoubZA, SauceD, et al. (2007) Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. The Journal of Experimental Medicine 204: 2473–2485.

32. CoffinJM (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267: 483–489.

33. BorrowP, LewickiH, WeiX, HorwitzMS, PefferN, et al. (1997) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Medicine 3: 205–211.

34. PriceDA, GoulderPJ, KlenermanP, SewellAK, EasterbrookPJ, et al. (1997) Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proceedings of the National Academy of Sciences of the United States of America 94: 1890–1895.

35. JonesNA, WeiX, FlowerDR, WongM, MichorF, et al. (2004) Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. The Journal of Experimental Medicine 200: 1243–1256.

36. MuddPA, EricsenAJ, BurwitzBJ, WilsonNA, O'ConnorDH, et al. (2012) Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllers. Journal of Immunology (Baltimore, Md: 1950) 188: 3364–3370.

37. JamiesonBD, YangOO, HultinL, HausnerMA, HultinP, et al. (2003) Epitope Escape Mutation and Decay of Human Immunodeficiency Virus Type 1-Specific CTL Responses. The Journal of Immunology 171: 5372–5379.

38. PhillipsRE, Rowland-JonesS, NixonDF, GotchFM, EdwardsJP, et al. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453–459.

39. GeelsMJ, CornelissenM, SchuitemakerH, AndersonK, KwaD, et al. (2003) Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. Journal of Virology 77: 12430–12440.

40. KoenigS, ConleyAJ, BrewahYA, JonesGM, LeathS, et al. (1995) Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nature Medicine 1: 330–336.

41. MempelTR, PittetMJ, KhazaieK, WeningerW, WeisslederR, et al. (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129–141.

42. WiedemannA, DepoilD, FaroudiM, ValituttiS (2006) Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proceedings of the National Academy of Sciences of the United States of America 103: 10985–10990.

43. MillerMJ, WeiSH, ParkerI, CahalanMD (2002) Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science (New York, NY) 296: 1869–1873.

44. MullerAJ, Filipe-SantosO, EberlG, AebischerT, SpathGF, et al. (2012) CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation. Immunity 37: 147–157.

45. GoonetillekeN, LiuMK, Salazar-GonzalezJF, FerrariG, GiorgiE, et al. (2009) The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206: 1253–1272.

46. MandlJN, RegoesRR, GarberDA, FeinbergMB (2007) Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J Virol 81: 11982–11991.

47. GanusovVV, GoonetillekeN, LiuMK, FerrariG, ShawGM, et al. (2011) Fitness costs and diversity of CTL response determine the rate of CTL escape during the acute and chronic phases of HIV infection. J Virol 85: 10518–10528.

48. AsquithB, McLeanAR (2007) In Vivo CD8+ T Cell Control of Immunodeficiency Virus Infection in Humans and Macaques. Proceedings of the National Academy of Sciences 104: 6365–6370.

49. AsquithB, EdwardsCT, LipsitchM, McLeanAR (2006) Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biology 4: e90.

50. FischerW, GanusovVV, GiorgiEE, HraberPT, KeeleBF, et al. Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing. PLoS ONE 5: e12303.

51. BeltmanJB, MaréeAFM, de BoerRJ (2007) Spatial modelling of brief and long interactions between T cells and dendritic cells. Immunology and Cell Biology 85: 306–314.

52. BeltmanJB, MaréeAFM, LynchJN, MillerMJ, de BoerRJ (2007) Lymph node topology dictates T cell migration behavior. The Journal of Experimental Medicine 204: 771–780.

53. GrawF, RegoesRR (2009) Investigating CTL Mediated Killing with a 3D Cellular Automaton. PLoS Comput Biol 5.

54. BauerAL, BeaucheminCAA, PerelsonAS (2009) Agent-based modeling of host-pathogen systems: The successes and challenges. Information Sciences 179: 1379–1389.

55. MempelTR, PittetMJ, KhazaieK, WeningerW, WeisslederR, et al. (2006) Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129–141.

56. Egen JacksonG, Rothfuchs AntonioG, Feng CarlG, Horwitz MarcusA, SherA, et al. (2011) Intravital Imaging Reveals Limited Antigen Presentation and T Cell Effector Function in Mycobacterial Granulomas. Immunity 34: 807–819.

57. MillerMJ, SafrinaO, ParkerI, CahalanMD (2004) Imaging the single cell dynamics of CD4+ T cell activation by dendritic cells in lymph nodes. The Journal of Experimental Medicine 200: 847–856.

58. MillerMJ, WeiSH, CahalanMD, ParkerI (2003) Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy. Proceedings of the National Academy of Sciences of the United States of America 100: 2604–2609.

59. BoissonnasA, FetlerL, ZeelenbergIS, HuguesS, AmigorenaS (2007) In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. The Journal of Experimental Medicine 204: 345–356.

60. WorbsT, MempelTR, BölterJ, von AndrianUH, FörsterR (2007) CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. The Journal of Experimental Medicine 204: 489–495.

61. AoshiT, ZinselmeyerBH, KonjufcaV, LynchJN, ZhangX, et al. (2008) Bacterial entry to the splenic white pulp initiates antigen presentation to CD8+ T cells. Immunity 29: 476–486.

62. BajénoffM, GlaichenhausN, GermainRN (2008) Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. Journal of Immunology (Baltimore, Md: 1950) 181: 3947–3954.

63. LittleSJ, McLeanAR, SpinaCA, RichmanDD, HavlirDV (1999) Viral dynamics of acute HIV-1 infection. The Journal of Experimental Medicine 190: 841–850.

64. NowakMA, LloydAL, VasquezGM, WiltroutTA, WahlLM, et al. (1997) Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. Journal of Virology 71: 7518–7525.

65. RibeiroRM, QinL, ChavezLL, LiD, SelfSG, et al. (2010) Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. Journal of Virology 84: 6096–6102.

66. HaaseAT (1999) Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annual Review of Immunology 17: 625–656.

67. SignoretN, Pelchen-MatthewsA, MackM, ProudfootAE, MarshM (2000) Endocytosis and recycling of the HIV coreceptor CCR5. The Journal of Cell Biology 151: 1281–1294.

68. MilicicA, EdwardsCTT, HuéS, FoxJ, BrownH, et al. (2005) Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants. Journal of Virology 79: 13953–13962.

69. Sanderson NSR, Puntel M, Kroeger KM, Bondale NS, Swerdlow M, et al.. (2012) Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells. Proceedings of the National Academy of Sciences of the United States of America 10.1073/pnas.1116058109.

70. GoulderPJ, PhillipsRE, ColbertRA, McAdamS, OggG, et al. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Medicine 3: 212–217.

71. BarouchDH (2008) Challenges in the Development of an HIV-1 Vaccine. Nature 455: 613–619.

72. FeeneyME, TangY, PfafferottK, RooseveltKA, DraenertR, et al. (2005) HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. Journal of Immunology (Baltimore, Md: 1950) 174: 7524–7530.

73. SaundersKO, Ward-CavinessC, SchutteRJ, FreelSA, OvermanRG, et al. (2011) Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage. Cellular Immunology 266: 154–164.

74. KadolskyUD, AsquithB (2010) Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes. PLoS Comput Biol 6: e1000981–e1000981.

75. HayCM, RuhlDJ, BasgozNO, WilsonCC, BillingsleyJM, et al. (1999) Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. Journal of Virology 73: 5509–5519.

76. GrawF, RegoesRR (2012) Influence of the fibroblastic reticular network on cell-cell interactions in lymphoid organs. PLoS Computational Biology 8: e1002436–e1002436.

77. MostowyR, KouyosRD, HoofI, HinkleyT, HaddadM, et al. (2012) Estimating the fitness cost of escape from HLA presentation in HIV-1 protease and reverse transcriptase. PLoS Computational Biology 8(5): e1002525 doi:10.1371/journal.pcbi.1002525

78. JungA, MaierR, VartanianJ-P, BocharovG, JungV, et al. (2002) Recombination: Multiply infected spleen cells in HIV patients. Nature 418: 144–144.

79. JosefssonL, KingMS, MakitaloB, BrännströmJ, ShaoW, et al. (2011) Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule. Proceedings of the National Academy of Sciences of the United States of America 108: 11199–11204.

80. MohriH, PerelsonAS, TungK, RibeiroRM, RamratnamB, et al. (2001) Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. The Journal of Experimental Medicine 194: 1277–1287.

81. BogleG, DunbarPR (2008) Simulating T-cell motility in the lymph node paracortex with a packed lattice geometry. Immunology and Cell Biology 86: 676–687.

82. StaffordMA, CoreyL, CaoY, DaarES, HoDD, et al. (2000) Modeling plasma virus concentration during primary HIV infection. Journal of Theoretical Biology 203: 285–301.

83. StrainMC, RichmanDD, WongJK, LevineH (2002) Spatiotemporal dynamics of HIV propagation. J Theor Biol 218: 85–96.

84. SchackerT, LittleS, ConnickE, GebhardK, ZhangZQ, et al. (2001) Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 183: 555–562.

85. FrostSD, DumaurierMJ, Wain-HobsonS, BrownAJ (2001) Genetic drift and within-host metapopulation dynamics of HIV-1 infection. Proc Natl Acad Sci U S A 98: 6975–6980.

86. McKeatingJ, BalfeP, ClaphamP, WeissRA (1991) Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity. J Virol 65: 4777–4785.

87. McKeatingJA, McKnightA, MooreJP (1991) Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J Virol 65: 852–860.

88. ZhangL, DaileyPJ, HeT, GettieA, BonhoefferS, et al. (1999) Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J Virol 73: 855–860.

89. RamratnamB, BonhoefferS, BinleyJ, HurleyA, ZhangL, et al. (1999) Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782–1785.

90. JollyC, KashefiK, HollinsheadM, SattentauQJ (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 199: 283–293.

91. RudnickaD, FeldmannJ, PorrotF, WietgrefeS, GuadagniniS, et al. (2009) Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 83: 6234–6246.

92. SourisseauM, Sol-FoulonN, PorrotF, BlanchetF, SchwartzO (2007) Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol 81: 1000–1012.

93. HubnerW, McNerneyGP, ChenP, DaleBM, GordonRE, et al. (2009) Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science 323: 1743–1747.

94. MazurovD, IlinskayaA, HeideckerG, LloydP, DerseD (2010) Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathog 6: e1000788.

95. AsquithB, DebacqC, MacallanDC, WillemsL, BanghamCRM (2002) Lymphocyte kinetics: the interpretation of labelling data. Trends in Immunology 23: 596–601.

96. DixitNM, MarkowitzM, HoDD, PerelsonAS (2004) Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy. Antiviral Therapy 9: 237–246.

97. PerelsonAS, NeumannAU, MarkowitzM, LeonardJM, HoDD (1996) HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science (New York, NY) 271: 1582–1586.

98. MarkowitzM, LouieM, HurleyA, SunE, Di MascioM, et al. (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. Journal of Virology 77: 5037–5038.

99. ZhengH, JinB, HenricksonSE, PerelsonAS, von AndrianUH, et al. (2008) How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Molecular and Cellular Biology 28: 4040–4051.

100. PerelsonAS, MackenCA, GrimmEA, RoosLS, BonavidaB (1984) Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte. Journal of Immunology (Baltimore, Md: 1950) 132: 2190–2198.

101. ZaguryD, BernardJ, JeannessonP, ThiernesseN, CerottiniJC (1979) Studies on the mechanism of T cell-mediated lysis at the single effector cell level. I. Kinetic analysis of lethal hits and target cell lysis in multicellular conjugates. Journal of Immunology (Baltimore, Md: 1950) 123: 1604–1609.

102. StinchcombeJC, GriffithsGM (2007) Secretory mechanisms in cell-mediated cytotoxicity. Annual Review of Cell and Developmental Biology 23: 495–517.

103. DushekO, AleksicM, WheelerRJ, ZhangH, CordobaS-P, et al. (2011) Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation. Science Signaling 4: ra39–ra39.

104. GonzálezPA, CarreñoLJ, CoombsD, MoraJE, PalmieriE, et al. (2005) T Cell Receptor Binding Kinetics Required for T Cell Activation Depend on the Density of Cognate Ligand on the Antigen-Presenting Cell. Proceedings of the National Academy of Sciences of the United States of America 102: 4824–4829.

105. KrogsgaardM, PradoN, AdamsEJ, HeX-l, ChowD-C, et al. (2003) Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Molecular Cell 12: 1367–1378.

106. AleksicM, DushekO, ZhangH, ShenderovE, ChenJ-L, et al. (2010) Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time. Immunity 32: 163–174.

107. ChervinAS, StoneJD, HollerPD, BaiA, ChenJ, et al. (2009) The Impact of TCR-Binding Properties and Antigen Presentation Format on T Cell Responsiveness. The Journal of Immunology 183: 1166–1178.

108. RegoesRR, YatesA, AntiaR (2007) Mathematical models of cytotoxic T-lymphocyte killing. Immunology and Cell Biology 85: 274–279.

109. IsaazS, BaetzK, OlsenK, PodackE, GriffithsGM (1995) Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. European Journal of Immunology 25: 1071–1079.

110. Pores-FernandoAT, BauerRA, WurthGA, ZweifachA (2005) Exocytic responses of single leukaemic human cytotoxic T lymphocytes stimulated by agents that bypass the T cell receptor. The Journal of Physiology 567: 891–903.

111. SlifkaMK, RodriguezF, WhittonJL (1999) Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 401: 76–79.